AUSTRALIS CAPITAL INC - AUSAF STOCK NEWS

Australis Capital Inc. (OTC: AUSAF) announced a binding terms sheet to acquire 100% of BW Macaw Group, Inc. for US$5 million payable in stock. This acquisition includes a retail license and allows cultivation, manufacturing, and distribution of cannabis products. The transaction aims to expand AUDACIOUS's footprint in California, enhancing market reach via a distribution agreement with EAZE, California's largest cannabis delivery service. Completion of the deal is subject to municipal and state approvals. The acquisition is expected to accelerate revenue growth and establish a retail presence in San Jose.

Australis Capital Inc., operating as AUDACIOUS, has secured a multi-year agreement with Professional Bull Riders (PBR) to be their 'Official CBD' partner. This partnership will introduce a full line of PBR-branded CBD topical products, including pain relief options, debuting at the PBR World Finals from November 3-7 in Las Vegas. The products will support brands in engaging a large audience of 83 million PBR fans and tap into a growing $23 billion CBD market in the U.S. Additionally, AUDACIOUS plans to build visibility through extensive marketing at PBR events.

Australis Capital Inc. (OTC: AUSAF) reported a remarkable 405% year-over-year revenue growth for Q4 FY 2021, achieving $3.0 million pre-tax profit compared to losses in previous quarters. The acquisition of ALPS significantly boosted revenues, with projections for Q1 FY 2022 showing a 277% sequential growth and a staggering 2,653% increase year-over-year. Despite holding ALPS for only 23 days in Q4, pro forma estimates suggest strong performance moving forward, driven by new partnerships and operational improvements.

Australis Capital Inc. (OTC: AUSAF) announced the filing of its fiscal fourth quarter and full-year results for 2021 on August 26, 2021, detailing performance up until March 31, 2021. The company expects trading to resume within 24-48 hours. Furthermore, it plans to file its first-quarter fiscal 2022 results on August 27, 2021. A conference call to discuss the results from both quarters is scheduled for August 30, 2021, at 11:00 AM ET. For further details, the company has provided contact information and replay options for interested investors.

Australis Capital Inc. (CSE: AUSA, OTC: AUSAF) announced a slight delay in the finalization of its audit, resulting in a cease trade order on its shares. The delay stems from complexities related to the legacy business and the intricate U.S. regulatory environment within the cannabis industry. The Company’s leadership emphasized that this is not indicative of its operational performance. CEO Terry Booth and CFO Jon Paul expressed confidence in completing the audit and resuming trading soon. Notably, AUSA acquired ALPS, expanding into the Sustainable Controlled Environment Agriculture sector.

Australis Capital Inc., operating as Audacious (CSE: AUSA, OTC: AUSAF), has signed a binding terms sheet to acquire Gary Maverick Inc., known for its LOOS cannabinoid-infused shot beverages, based in Santa Cruz, California. This strategic acquisition aims to expand Audacious's product portfolio into the rapidly growing THC and CBD beverage categories, tapping into a projected $1.4 billion U.S. market by 2023. LOOS's management team, recognized for their success in California's edibles market, brings expertise to enhance distribution and accelerate market entry with innovative products.

Audacious Brands (CSE: AUSA) has entered into a significant partnership with Belle Fleur Holdings, which includes a cannabis supply agreement, a facility engineering contract via ALPS, and ongoing compliance services. Belle Fleur will allocate part of its licensed canopy space for cultivating Audacious' proprietary strains under a cost-plus agreement. This collaboration capitalizes on Belle Fleur’s established market presence and premium genetics, aiming to enhance Audacious' footprint in Massachusetts and potentially other Eastern U.S. markets. The agreement facilitates long-term access to cost-effective, high-quality cannabis, reinforcing their growth strategy.

Australis Capital (CSE: AUSA, OTC: AUSAF) has announced significant findings from a University of Alberta study co-led by its Chief Science Officer, Dr. Jason Dyck. The study shows a strong correlation between medical cannabis use and reduced opioid consumption among patients in Alberta. The company also appointed Hanoz Kapadia as Chairman of the Board, emphasizing governance and innovation in the cannabis sector. Furthermore, AUSA's subsidiary, ALPS, is advancing agricultural technologies and has secured a contract in the Middle East. The firm aims to become a leading multi-state operator in the cannabis industry.